Mission
At Almathera, we are dedicated to enhancing healthcare in Central Asia by providing advanced theranostics and radiopharmacy solutions.
Our goal is to create a regional center that improves access to critical cancer treatments, offering life-saving therapies and contributing to healthcare progress in the region.
At Almathera, we are dedicated to enhancing healthcare in Central Asia by providing advanced theranostics and radiopharmacy solutions.
Our goal is to create a regional center that improves access to critical cancer treatments, offering life-saving therapies and contributing to healthcare progress in the region.
Creating a facility for the production
of radiopharmaceutical drugs in compliance with GMP standards, serving local and global oncology clinics and diagnostic centers
of radiopharmaceutical drugs in compliance with GMP standards, serving local and global oncology clinics and diagnostic centers
Pioneering Theranostics | Empowering Innovation
CURRENT STATUS
- Our facility is in the pre-design phase, with detailed design work underway
- Construction is planned to begin in the fall of 2025
- Testing and operational trials are anticipated Q1 2027
THERANOSTICS SOLUTIONS
Our products:
Ga-68
Cu-64
Lu-177
Ga-68
Cu-64
Lu-177
CDMO SERVICES
We offer full-scale CDMO services, from development to manufacturing, ensuring that your projects meet the highest quality standards
R&D
COLLABORATION
COLLABORATION
Our open-minded platform welcomes partnerships for research and development, fostering innovation in radiopharmaceuticals and isotope production
TECHNOLOGICAL PARTNERS
SCIENTIFIC PARTNERS
INFORMATION PARTNERS
Significance of the project
Main advantages
1
It will reduce the issue of availability of high-tech and innovative molecular imaging methods and personalized radioligand therapy (theranostics with Lu177)
2
It will enable the development and production of radiopharmaceuticals for theranostics of various diseases, primarily for endocrine and oncological conditions
3
It will become a new point on the global map of logistics and GMP (Good Manufacturing Practice) production of Lu177 radiopharmaceuticals
4
It will establish a unique multidisciplinary cluster of experts, including medical professionals, biologists, chemists, and physicists, with the participation of international partners
5
Additional job opportunities for young and promising specialists in the fields of radiopharmaceuticals, radiochemistry, nuclear medicine, medical physics, radiobiology, IT technologies, etc.
PROCESS Lu 177
IRRADIATION OF YB-176 TARGET IN THE REACTOR
TECHNOLOGY NCA
LU-177
LU-177
PACKAGING IN A MULTI-DOSE VIAL NCA LU-177 GMP EU SUBSTANCE
RADIOLIGAND BINDING TECHNOLOGY
PACKAGING IN A
MULTI-DOSE VIAL NCA
LU-177 - RADIOLIGAND
(GMP EU)
MULTI-DOSE VIAL NCA
LU-177 - RADIOLIGAND
(GMP EU)
PROCESS Ga 68 | Cu 64
CYCLOTRON PRODUCTION OF ISOTOPES
USING LIQUID TARGETS OF IBA
RADIOCHEMICAL SYNTHESIS TECHNOLOGY
PSMA-FAPI-DOTA Ga-PSMA-DOTA-Peptides
PACKAGING IN A MULTI-DOSE VIAL OF A RADIOPHARMACEUTICAL
FOR PET DIAGNOSTICS (GMP EU)
Location plan
Location of the projected site on the territory of the SEZ Park of Innovative Technologies
Location of the projected site on the territory of the SEZ Park of Innovative Technologies
BECOME PART OF OUR TEAM
We are hiring a high-level specialists
News